Virag Sharon 4
4 · NEOGENOMICS INC · Filed Mar 28, 2018
Insider Transaction Report
Form 4
Virag Sharon
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-03-27$8.22/sh+192,500$1,582,350→ 192,500 totalExercise: $8.22From: 2019-03-27Exp: 2023-03-27→ Common Stock (192,500 underlying)
Footnotes (1)
- [F1]On March 27, 2018, Ms. Virag was granted an option to purchase shares of NeoGenomics, Inc. common stock. The option vests ratably over the first three anniversary dates of the grant date.